I'm writing on Issue 5: Because of the public's investments made in drug research through universities and federal agencies such as the National Institutes of Health, the profits that pharmaceutical companies earn on drugs should be regulated.
POSITION: Regulation of phramaceutical company profits results in the leveling of pricing standards in public and private research, however, regulation is possible only at the expense of innovative drug development. Regulation may also be deemed an onerous task for policymakers, as evidenced in various foreign countries where public and private research have been supervised by equal integrity, review, protocol, and fiscal standards.
CONTRIBUTED BY stellar205
Links to this Page